Jane Street’s Third Harmonic Bio THRD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-23,876
Closed -$119K 10881
2025
Q1
$82.8K Buy
23,876
+4,384
+22% +$21.3K ﹤0.01% 8882
2024
Q4
$201K Buy
+19,492
New +$243K ﹤0.01% 8412
2024
Q3
Sell
-21,405
Closed -$278K 10392
2024
Q2
$278K Sell
21,405
-612
-3% -$7.57K ﹤0.01% 7917
2024
Q1
$208K Buy
22,017
+9,880
+81% +$96K ﹤0.01% 8131
2023
Q4
$133K Buy
+12,137
New +$96.1K ﹤0.01% 8454
2022
Q4
Sell
-18,809
Closed -$357K 10143
2022
Q3
$357K Buy
+18,809
New +$339K ﹤0.01% 7299

Other funds holding THRD

Jane Street's THRD Position: Q2 2025 in Review

Jane Street sold out of Third Harmonic Bio (THRD) in Q2 2025, closing a stake of 23,876 shares — an estimated $119K sold.

Jane Street first reported a position in THRD in Q3 2022 and held it in 6 quarters. The position peaked at $357K in Q3 2022. 105 funds tracked by Wall St. Rank hold THRD as of Q2 2025.

  • Jane Street reported no remaining Third Harmonic Bio position as of Q2 2025 after selling out during the quarter.
  • Jane Street sold 23,876 Third Harmonic Bio shares in Q2 2025, an estimated $119K.
  • Jane Street first reported a position in Third Harmonic Bio in Q3 2022 and held it in 6 quarters.
  • Jane Street's Third Harmonic Bio position peaked at $357K in Q3 2022.
  • 105 funds tracked by Wall St. Rank held Third Harmonic Bio as of Q2 2025.

Based on Jane Street's 13F filing for Q2 2025, filed 14 Aug 2025.